Chart review versus an automated bioinformatic approach to assess real-world crizotinib effectiveness in ALK-positive NSCLC
JCO Clin Cancer Inform
.
2017:1:10.1200/CCI.16.00055.
doi: 10.1200/CCI.16.00055.
Epub 2017 Mar 13.
Authors
Nam Bui
1
,
Solomon Henry
2
,
Douglas Wood
2
,
Heather A Wakelee
3
,
Joel W Neal
3
Affiliations
1
Division of Hematology and Oncology, University of California, San Diego School of Medicine, UCSD Moores Cancer Center, San Diego, CA, USA.
2
Stanford Cancer Institute - Affiliated, Stanford, CA, USA.
3
Stanford Cancer Institute, Stanford, CA, USA.
PMID:
28868517
PMCID:
PMC5575933
DOI:
10.1200/CCI.16.00055
No abstract available
Keywords:
Anaplastic lymphoma kinase; Informatics; Non-small cell lung cancer.
Grants and funding
P30 CA124435/CA/NCI NIH HHS/United States